Analytical Data
-
基因名
MT1M
- Application
-
别名
MT1M;MT1K;Metallothionein-1M
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N339
-
表达区间
1-61aa
-
氨基酸序列
MDPNCSCTTG VSCACTGSCT CKECKCTSCK KSCCSCCPVG CAKCAHGCVC KGTLENCSCC A
-
分子量
6.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MT1M, or metallothionein 1M, is a low-molecular-weight protein characterized by its high cysteine content, which allows it to bind heavy metals and reactive oxygen species. This protein is part of a larger family of metallothioneins known for their role in metal homeostasis, detoxification, and protection against oxidative stress. Research indicates that MT1M is involved in various biological processes, including cellular signaling, apoptosis, and the response to environmental stress. Its expression is often upregulated in response to heavy metal exposure, highlighting its potential role in metal detoxification mechanisms. Furthermore, studies have shown that MT1M may be associated with certain pathological conditions, including cancer and neurodegenerative diseases, further emphasizing its significance in health and disease. The understanding of MT1M's structure, function, and regulation is critical for elucidating its role in these processes and could lead to potential therapeutic applications, including the development of strategies to manipulate its expression or activity in disease contexts. As research continues to unravel the complexities of MT1M, it offers promising insights into the broader implications of metallothioneins in physiological and pathological states.












